• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    Sarepta Therapeutics, Inc. (SRPT)

    -NasdaqGS
    12.22 Down 0.01(0.08%) Feb 5, 4:00PM EST
    |After Hours : 12.07 Down 0.15 (1.23%) Feb 5, 7:50PM EST
    Prev Close:12.23
    Open:12.08
    Bid:12.05 x 900
    Ask:12.20 x 100
    1y Target Est:35.25
    Beta:0.887301
    Earnings Date:Feb 24 - Feb 29 (Est.)
    Day's Range:11.68 - 12.28
    52wk Range:11.10 - 41.97
    Volume:1,335,359
    Avg Vol (3m):1,930,700
    Market Cap:553.21M
    P/E (ttm):N/A
    EPS (ttm):-4.83
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SRPT

    Comparison

    Symbol% ChgMkt Cap
    SRPTDown 0.08%553.21M
    GSKDown 0.54%98.64B
    ALNYDown 2.84%5.56B
    ISIS 0.00%6.91B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):20,506.09
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-4.87
    Quarterly EPS Est (Dec-15) :-1.19
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):12.55

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback